FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Remifentanil Injection
Status: Currently in Shortage
»Date first posted: 06/28/2022
»Therapeutic Categories: Analgesia/Addiction

Expand all

Fresenius Kabi USA (Reverified 03/31/2023)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
1 mg per vial, SDV (NDC 63323-723-03)	Backordered. Next release April 2023.	Check wholesaler inventory	Demand increase for the drug
2 mg per vial, SDV (NDC 63323-724-05)	Available	Check wholesaler inventory	Demand increase for the drug
5 mg per vial, SDV (NDC 63323-725-10)	Available	Check wholesaler inventory	Demand increase for the drug

Hikma Pharmaceuticals (Revised 08/26/2022)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
1 mg/vial (NDC 0143-9391-10)	This presentation is on backorder. Product will be available September 2022		Demand increase for the drug
2 mg/Vial (NDC 0143-9392-10)	This presentation is on backorder. Product will be available September 2022		Demand increase for the drug
5 mg/mL (NDC 0143-9393-10)	Currently available		Demand increase for the drug

Mylan, a Viatris Company (Reverified 03/28/2023)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
ULTIVA 1 mg (NDC 67457-198-03)	Available		Demand increase for the drug
ULTIVA 2 mg (NDC 67457-198-05)	Available		Demand increase for the drug
ULTIVA 5 mg (NDC 67457-198-10)	Available		Demand increase for the drug